Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_2683_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
40 Мб
Скачать
This page intentionally left blank

Jaundice

Liver
T
e bowel
Faecal excretionUrinary excretion
Kidney
14

INTRODUCTION

Jaundice (icterus) is the yellow discoloration of the skin, sclera and mucosae that is detectable when serum bilirubin concentrations exceed approximately 35 μmol/L. Normal bilirubin metabolism is summarized in Fig.14.1. Jaundice can arise because of increased red blood cell breakdown, dis­ordered bilirubin metabolism or reduced bilirubin excretion.
Erythrocyte breakdown in the reticuloendothelial system
Biliverdin
Unconjugated bilirubin (water insoluble)
transported to liver bound to albumin
Hepatic conjugation with glucuronic acid
Conjugated bilirubin
Excreted into bile and passed to terminal ileum
Enterohepatic
circulation
erminal ileum
Urobilinogen
Systemic circulation Oxidation in larg
Fig.14.1 Normal bilirubin metabolism.
Bacterial action in terminal ileum
Stercobilinogen
The causes of jaundice are outlined in Table 14.1. Prehepatic jaundice (unconjugated hyperbilirubinaemia) usually results from the excessive production of bilirubin by haemolysis (see Fig. 14.1), in haemolytic anaemia for instance, but it can also result from inherited metabolic de­fects, the commonest of which is Gilbert syndrome. Hepatic jaundice results from hepatocyte dysfunction causing dis­ordered bilirubin metabolism. Hepatocellular dysfunction usually causes some cholestasis and may cause ‘pale stools/ dark urine’ (see later). Posthepatic jaundice (cholestasis) is caused by reduced bilirubin excretion due to intrahepatic or extrahepatic biliary obstruction.

HISTORY AND EXAMINATION

History

Ask about:
• Pruritus, dark urine and pale stools: underlying
cholestasis.
• Abdominal pain: the episodic, colicky, right
hypochondrial pain of biliary colic will commonly be due to gallstones. A dull, persistent epigastric or central pain radiating to the back may suggest a pancreatic origin.
• Fevers or rigors: cholangitis.
• Weight loss: underlying malignancy, particularly
pancreatic cancer.
• Duration of illness: a short history of malaise, anorexia
and myalgia is suggestive of viral hepatitis.
• Drug history: particularly paracetamol, oral
contraceptive pill.
• Alcohol consumption: acute alcoholic hepatitis,
cirrhosis.
• Infectious contacts: hepatitis A.
• Recent foreign travel to areas of high hepatitis risk.
• Recent surgery: surgery for known malignancy, biliary
stricture due to previous endoscopic retrograde cholangiopancreatography (if the patient had a sphincterotomy).
• Intravenous drug abuse, tattoos, unprotected sex:
increased risk of hepatitis B and hepatitis C.
• Occupation: sewage workers and people who
participate in open water sports and activities are at increased risk of leptospirosis.
• Family history of recurrent jaundice: inherited
haemolytic anaemias and Gilbert syndrome.
89
Jaundice
Head
— Y — Anaemi — Fetor hepaticus — Xanthelasmata — Kayser–Fleischer rings — Drowsiness — Constructional
Abdomen
— Hepatomegaly — Splenomegal — Palpable gallbladder — Caput medusae — Ascite
Chest and arms
— Scratch marks — Spider naevi — Gynaecomastia — Loss of body hai — Bruising — Needle marks — T
Hands
— Leuconychia — Palmar erythema — Clubbing — Dupuytren contracture — Asterixi
Table14.1 The differential diagnosis of jaundice
Prehepatic (see
Chapter36) Hepatic (see Chapter29) Posthepatic (see Chapter29)
Acute hepatocellular
damage
Haemolysis Viral infection (e.g.
hepatitis A, B, C, E; EBV; CMV)
CMV, Cytomegalovirus; EBV, Epstein-Barr virus.
Chronic hepatocellular damage
Inherited defects (e.g. primary haemochromatosis, Wilson disease, α1-antitrypsin deficiency)
Extrahepatic obstruction
Intrahepatic obstruction
Gallstones Primary biliary cirrhosis

Examination

The causes of jaundice are multiple and may therefore indicate underlying disease in one of many organ sys­tems. There are three important groups of abnormalities that should specifically be looked for in the jaundiced patient:
• How severe is the jaundice? Is there any evidence of encephalopathy?
• Is this an acute or a chronic problem? Are there any signs of chronic liver disease?
• Are there any signs of specific disorders?
This approach is summarized in Fig.14.2.
CLINICAL NOTE
ENCEPHALOPATHY
Encephalopathy is defined as disordered brain function. The following suggest encephalopathy:
• Drowsiness: this will eventually progress through stupor to coma.
• Slurred speech.
• Asterixis: flapping tremor of outstretched hands.
• Seizures.
• Constructional apraxia: test for this by asking the patient to copy a five-pointed star.
• Hepatic fetor: mercaptans pass directly into the lungs because of portal hypertension, causing a characteristic odour of the patient’s exhaled breath.
ellow sclera and mucosae
a
apraxia
r
attoos
y
s
s
Testicular atrophy
Peripheral oedema
Fig.14.2 Examining the patient with jaundice.
CLINICAL NOTES
SIGNS OF CHRONIC LIVER DISEASE
Hepatic encephalopathy can arise because of fulminating acute liver failure or when chronic disease decompensates. Precipitating factors, grading and management are de­scribed in Chapter29.
90
• Palmar erythema.
• Leuconychia and oedema: hypoalbuminaemia.
• Clubbing.

Investigations

1414
• Dupuytren contractures: particularly in alcoholic cirrhosis.
• Spider naevi: more than five in the distribution of the superior vena cava.
• Scratch marks: cholestasis.
• Gynaecomastia, loss of body hair and testicular atrophy: elevated oestrogen level.
• Bruising: disordered coagulation.
• Hepatomegaly: not in well-established cirrhosis.
• Splenomegaly, ascites and caput medusae: portal hypertension.
Signs of specific diseases:
• Xanthelasmata: primary biliary cirrhosis.
• Kayser–Fleischer rings: Wilson disease.
• Slate-grey pigmentation: haemochromatosis.
• Hard, irregular hepatomegaly: malignant metastases.
• Nontender, palpable gallbladder: jaundice is unlikely to be caused by gallstones (Courvoisier's law).
• Parotid gland enlargement: alcohol.
• Needle marks or tattoos: hepatitis B, hepatitis C.
INVESTIGATIONS
The investigation of jaundiced patients falls into two stages. First the type of jaundice must be determined (prehepatic, hepatic or posthepatic); then more detailed tests should be performed to determine the specific cause. Fig.14.3 sum­marizes this approach.
Table14.2 describes biochemical abnormalities in differ-
ent types of jaundice.
• Blood tests: Conjugated bilirubin, alanine transaminase, aspartate transaminase, alkaline phosphatase, γ- glutamyltransferase: will give a reasonable indication as to the type of abnormality present. Alkaline phosphatase level is commonly raised in biliary disorders but is also elevated in pregnancy. Raised alanine transaminase and aspartate transaminase levels indicate hepatocellular dysfunction. γ-Glutamyltranspeptidase level is raised in the case of alcohol excess.
• Urinary bilirubin and urobilinogen: urine is normally free of bilirubin. Dark urine indicates the presence of conjugated bilirubin. Low urobilinogen level suggests obstructive jaundice, whereas raised urobilinogen level suggests haemolysis or intrahepatic damage.
Jaundice
Specific clues in
history or examination
No
Urine dipstick
Serum liver enzymes and bilirubin
Abdominal ultrasound scan
Haemolysis
Appropriate
confirmatory tests
Fig.14.3 Investigation of the patient with jaundice. Computed tomography (CT) and magnetic resonance cholangiopancreatography (MRCP) are usually performed before endoscopic retrograde cholangiopancreatography (ERCP) or percutaneous transhepatic cholangiography (PTC). EUS, Endoscopic ultrasonography.
Biliary
dilatation
ERCP/PTC/
CT pancreas/
MRCP/EUS
Yes
Appropriate
confirmatory tests
Normal
biliary tree
Viral serology
Autoantibodies
Immunoglobulins
Ferritin
Caeruloplasmin
-antitrypsin
a
1
Liver biopsy
91
Jaundice
Table14.2 Biochemical abnormalities in different types of jaundice
Specimen Test Haemolysis Hepatocellular Cholestasis
Urine Urobilinogen
Conjugated bilirubin
Faeces Stercobilinogen Raised level Normal or decreased
Blood Bilirubin
Liver enzymes
ALT, alanine transaminase; AST, aspartate transaminase; GCT, γ-glutamyltransferase.
Raised level Absent
Unconjugated Normal levels
Normal or raised level Present
level
Unconjugated and conjugated AST, ALT
Decreased level or absent Raised
Decreased level or absent
Conjugated Alkaline phosphatase, GGT
• Abdominal ultrasound scan, CT scan, magnetic resonance cholangiopancreatography (MRCP), endoscopic retrograde cholangiopancreatography (ERCP): to investigate the cause.
• Serum caeruloplasmin: Wilson disease.
α1-Antitrypsin.
• Liver biopsy: definitive diagnostic test for intrinsic liver disease.
• Fasting lipid profile: triglycerides for steatosis.

Haemolysis screen

The haemolysis screen is detailed in Chapter29.
HINTS AND TIPS

Hepatocellular screen

• Viral serology: hepatitis A, B and C; EBV, CMV.
• Autoantibody screen: antimitochondrial antibodies (levels raised in primary biliary cirrhosis), anti-smooth muscle antibodies, antinuclear antibodies.
• Ferritin: haemochromatosis.
Chapter Summary
• Bilirubin is the breakdown product of haemoglobin.
• Jaundice becomes apparent if bilirubin level is greater than 35 μmol/L.
• Jaundice can be of prehepatic, hepatic or posthepatic origin.
• The history and examination, together with investigations, will point towards the cause.
• Management depends on the underlying disease.
Liver dysfunction affects the synthesis of clotting factors, and therefore the prothrombin time must be checked and corrected before an invasive procedure (e.g. liver biopsy).
92
Urinary symptoms and

INTRODUCTION

The volume of water in the circulation is under constant physiological control. Water is normally reabsorbed from the loop of Henle as it passes through the hyperosmolar renal medulla, and is also reabsorbed from the collecting ducts under the control of antidiuretic hormone (ADH), also called ‘vasopressin’ (Fig. 15.1). ADH is synthesized by the hypothalamus and released from the posterior pituitary in response to a rise in serum osmolality or fall in plasma volume. Conversely, a fall in osmolality or rise in plasma volume leads to a decrease in ADH secretion.
Polyuria is defined as the passage of excessive volumes of urine (>3 L in 24 h). Urine output depends on fluid in­take and loss via other routes (e.g. respiration, sweat, fae­ces), and typically ranges from 1 to 3 L/day. Polydipsia is defined as excessive thirst, often manifested as the ingestion of excessive volumes of fluid, and is usually a consequence of polyuria.
haematuria
15
Frequency is the frequent passage of small volumes of urine, and dysuria is pain on passing urine. Symptoms of blad­der outflow obstruction, such as those caused by an enlarged prostate gland, include hesitancy (difficulty initiating mic­turition), terminal dribbling and poor stream. Nocturia, the passage of urine at night, may be associated with frequency or polyuria. Urinary incontinence is common, and is broadly divided into stress incontinence and urge incontinence.
Oliguria and anuria, the passage of small volumes or no urine, respectively, may be due to renal impairment or uri­nary tract obstruction (see Chapter30).
HINTS AND TIPS
There are many causes of polyuria, but those seen most commonly in clinical practice are hyperglycaemia and hypercalcaemia.
Distal
tubule
Hypo-
osmolar
+
Na
+
K
2Cl
Thin
+
Na –
Cl
ascending limb
Loop of Henle
H
O
2
Thick ascending limb
+
Na
Cl
H
2
Impermeable
O
to H
2
O
Collecting
+
O
2
H
Thin
limb
2
Proximal
tubule
O
Hyperosmolar
Cortex
Na
H
Iso-osmolar
Outer medulla
descending
Inner medulla
Fig.15.1 Water and electrolyte balance in the loop of Henle. ADH, antidiuretic hormone.
ADH
duct
93
Urinary symptoms and haematuria
The differential diagnosis of polyuria/polydipsia is summa­rized in Table15.1.
Frequency is commonly due to bladder irritation, which is often due to infection but can also be caused by chemical irritation, tumours or calculi in the bladder.
CLINICAL NOTES
Symptoms of prostatic hypertrophy include poor stream, hesitancy, postmicturition dribbling and incomplete emptying. Nocturia is a troubling symptom. Ask the patient about sleep disturbance.
Dysuria is most commonly due to infection, but can also be caused by chemical irritation. When accompanied by frequency, it may indicate cystitis, and in men may also be caused by prostatitis.
Stress incontinence is common in women and is often due to weakened pelvic floor muscles resulting from phys­ical changes following pregnancy and childbirth. Urge incontinence is associated with detrusor instability and in­appropriate contraction, which may be a consequence of lo­cal factors such as infection or inflammation, or may be due to damage to the nerve supply. Innervation is mainly from the autonomic nervous system, although there is voluntary
control of the external urinary sphincter, and higher control of urination in the micturition centre of the pons.
Micturition disturbances
History and examination findings
For many urinary symptoms, there will be a simple expla­nation, for instance infection or prostatic hypertrophy. The history should focus on the following points:
• Frequency: is there coexistent fever, dysuria or cloudy urine (pyuria) which may indicate infection? If so, is there a history of recurrent infection that might indicate a predisposition (e.g. diabetes, urinary stasis, immunosuppression)? In men, are there associated symptoms of prostatic hypertrophy; is there urinary stasis from incomplete bladder emptying?
• Does the patient have loin pain, or a history of renal calculi?
• Is there associated haematuria? In the presence of other lower urinary tract symptoms this could be due to infection, calculus or bladder tumour.
• If incontinence is present, be careful to determine the circumstances in which it occurs and the effect it is having on the patient's everyday activities.
• The patient's current medication may provide clues as to the cause (e.g. is the patient taking diuretics?).
Table15.1 Differential diagnosis of polyuria
Causes Examples/notes
Cranial DI (insufficient ADH secretion) Idiopathic (often familial and commonest form)
Nephrogenic DI (inability of kidney to respond to ADH)
Chronic renal failure Can result in depressed kidney concentrating ability and therefore higher urine
Acute renal failure Diuretic phase of ATN
Osmotic diuresis Glucose (diabetes mellitus)
ANP release Arrhythmia (e.g. after SVT)
Psychogenic polydipsia Relatively common psychiatric disturbance characterized by excessive water
ADH, Antidiuretic hormone; ANP, atrial natriuretic peptide; ATN, acute tubular necrosis; DI, diabetes insipidus; SVT, supraventricular tachycardia.
After pituitary surgery/irradiation After head trauma Malignancy (e.g. craniopharyngioma, pinealoma, glioma, metastases) Infections (e.g. meningitis) Infiltrations (e.g. sarcoid and histiocytosis X) Drugs (e.g. alcohol)
Congenital (primary renal tubular defect) Electrolyte imbalance (hypokalaemia and hypercalcaemia) Lithium toxicity Long-standing pyelonephritis or hydronephrosis
volume to excrete a given solute load
Following relief of obstructive uropathy Early stages of analgesic nephropathy
Calcium (hypercalcaemia)
intake (if prolonged can cause temporary ‘renal medullary washout’ with reduction of kidney’s concentrating ability)
94
Introduction
Heart
—Cardiac examination —Tachycardia
—Hypertensive nephropathy
(chronic renal failure)
1515
Polyuria and polydipsia may pose a more difficult di­agnostic challenge, and after general questions the enquiry should focus on the following:
• Differentiation between polyuria (an increase in the
volume of urine production) and frequency (the frequent passage of small amounts of urine).
• Weight loss: associated with malignancy which may
result in hypercalcaemia (e.g. bone metastases of bone infiltration in myeloma may cause hypercalcaemia).
• Headache: primary or secondary brain tumours can
cause diabetes insipidus.
• Family history: this is relevant in diabetes mellitus,
both forms of diabetes insipidus (cranial and nephrogenic) and renal stone disease.
• Medical history: consider previous neurosurgery
or radiotherapy, head injuries and meningitis in particular.
Eyes
—Papilloedema (raised intracranial pressure) —Diabetic or hypertensive fundi —Visual field defects —Anaemia (carcinoma or chronic renal failue)
• Drug history: lithium may cause nephrogenic diabetes insipidus; vitamin D or milk–alkali syndrome may lead to hypercalcaemia.
• Recurrent infections: may be due to diabetes mellitus.
• Features of hypercalcaemia (see Chapter 31).
• Brief psychiatric history: especially if thirst is predominant. These patients may drink surreptitiously, resist investigation, have other neurotic symptoms and lack nocturnal symptoms.
Examination
The examination approach in the patient with urinary symptoms is summarized in Fig.15.2.
General appearance
• Wasting/cachexia (malignancy and initial presentation of type 1 diabetes mellitus) and hydration status.
Lymph nodes/liver/spleen
—Malignancy —Infiltrative disorder
Blood pressure
Fig.15.2 Examining the patient with polyuria or polydipsia. ANP, atrial natriuretic peptide.
elevated
ANP polyuria
Kidneys
—Enlarged (polycystic kidney disease, hydronephrosis)
Bladder
—Obstruction
Reflexes
—Reduced in hypokalaemia
Skin
—Yellow-brown skin (uraemia) —Signs of infection (diabetes) —Signs of malignancy
Extremities
—Peripheral neuropathy (diabetes) —Pulses (diabetes)
Hands
—Clubbing (bronchial carcinoma) —Brown arcs on nails
General appearance
—Cushingoid facies —Wasting (malignancy, diabetes) —Hydration status
95
Urinary symptoms and haematuria
• Skin manifestations: diabetes mellitus and malignancy (see Chapter35).
• Nails: clubbing—associated with bronchogenic carcinoma, which may produce parathyroid hormone (and result in hypercalcaemia), or may metastasize to the brain.
• Anaemia: malignancy or chronic renal failure.
• Lymphadenopathy: malignancy or infiltrative disorder.
• Optic signs: fundal changes of hypertension or diabetes.
Cardiovascular system
Check the blood pressure for hypertensive nephropathy.
Abdominal examination
Palpate the kidneys carefully as they may be enlarged in polycystic kidney disease or with a hydronephrosis. A large bladder may indicate urinary tract obstruction. The liver and spleen may be enlarged in malignancy and infiltrative disorders. An enlarged or craggy prostate can often be pal­pated on rectal examination.
Neurological examination
The neurological examination should assess:
• peripheral neuropathy (caused by diabetes or infiltrative disorders);
• hypotonia and areflexia with hypokalaemia;
• wasting in malignancy;
• visual fields (classically bitemporal hemianopia with pituitary disease) and papilloedema (raised intracranial pressure);
• in idiopathic urge incontinence if there is evidence of any underlying neurological abnormality.
Investigations
The following investigations should be carried out.
Urine tests
• Simple urinalysis (urine dip) will give a pH, and detect protein, blood, glucose and ketones, as well as leucocytes and nitrites, the presence of which may indicate infection.
• Laboratory urine analysis can measure urine osmolality. Quantify protein loss, with protein/ creatinine or albumin/creatinine ratios. Urinary electrolytes, including sodium, potassium, phosphate, calcium and oxalate, can be measured. Urine microscopy may reveal the presence of blood cells, bacteria or casts, and culture may reveal a pathogenic organism.
Blood tests
• Biochemistry: renal failure (see Chapter30), hypercalcaemia, hypokalaemia (see Chapter31) and hyperglycaemia.
• Full blood count: anaemia with chronic renal failure or malignancy (e.g. leukaemia, myeloma). Raised white cell count suggests infection.
Imaging
• Chest X-ray: if any suspicion of sarcoidosis, primary or secondary malignancy.
• Renal tract ultrasound scan can detect abnormal kidney size, cysts and masses, congenital defects of the renal tract, hydronephrosis or hydroureter.
• CT of the kidneys/ureters/bladder if there is suspicion of renal tract calculi (this can be a noncontrast CT scan).
• CT or MRI of brain to investigate intracranial disease (e.g. if you are considering a space-occupying lesion).
Further investigations
• Renal concentration tests in polyuria: if either a hypothalamic or a pituitary cause or renal tubular dysfunction is suspected. It is mandatory to exclude other potential causes of polyuria, as renal concentration tests may be dangerous. The patient is asked to drink nothing from 16:00 the day before attending the outpatient department. If the urine osmolality the next morning is not greater than 800 mmol/kg, inpatient tests are required (Box 15.1 and Table 15.2).
• Urodynamic tests: these commonly measure the prevoid and postvoid bladder volume and flow rate to assess bladder emptying.
• Nuclear renography: radioisotope uptake scans (e.g. dimercaptosuccinic acid (DMSA) or mercaptoacetyltriglycine (MAG3) scans) can provide detailed information about asymmetric kidney function and can evaluate kidney scarring.
Haematuria
This should be classified as visible or nonvisible, painful or painless and whether it is associated with proteinuria. Haematuria and proteinuria together is suggestive of intrin­sic renal damage, and is discussed in Chapter30. Painful
BOX15.1 PROCEDURE FOR TESTING PATIENTS WITH POLYURIA AND POLYDIPSIA
• Weigh the patient.
• Deprive the patient of all fluids the night before the tests.
• The next morning, weigh the patient every 2 h (a decrease in weight by >3% indicates dehydration, so stop the test).
• Collect urine and blood for osmolality measurement.
• If the urine osmolality fails to reach 800 mmol/ kg, intramuscularly administer desmopressin (which is synthetic vasopressin), which acts in the same way as ADH.
• Collect blood and urine for osmolality measurement.
96
Introduction
Table15.2 Interpretation of patient test results
Fluid deprivation
Pituitary DI
Psychogenic polydipsia
Nephrogenic DI
a
Urine is concentrated, but less than in normal response
DI, diabetes insipidus; , increase in osmolality; , no significant change in osmolality.
Plasma osmolality Urine osmolality Plasma osmolality Urine osmolality
a
After intramuscular administration of
desmopressin
1515
haematuria may suggest renal calculus or urinary tract in­fection; painless haematuria suggests the possibility of renal tract malignancy. Remember that red urine may also be due to haemoglobinuria, myoglobinuria, porphyria, drugs (e.g. rifampicin) or even the ingestion of beetroot.
Haematuria can come from anywhere in the urogen­ital tract. It can be classified by the site of disease (see
Table 15.3). Systemic conditions (e.g. thrombocytopenia)
or anticoagulants can predispose to bleeding.
CLINICAL NOTES
If haematuria is present in a young woman, it is important to ask about the menstrual cycle and whether she was menstruating when the haematuria was noticed.
Table15.3 Causes of haematuria from the urinary tract
Site Causes
Kidney Infections (pyelonephritis, tuberculosis)
Tumours (renal cell carcinoma) Trauma (spontaneous or after renal biopsy) Papillary necrosis (associated with diabetes)
Ureters Renal calculi
Tumours; transitional cell Trauma
Bladder Cystitis; infection, postradiation cystitis
Tumours; transitional cell carcinoma Trauma Bladder calculi Infections; tuberculosis and schistosomiasis
Prostate Prostate carcinoma
Benign prostatic hypertrophy Infection; prostatitis
Urethra Calculi
Trauma Tumours Foreign bodies
History and examination findings
• Ask about the appearance of the urine. Is there frank blood (malignancy)?
• Ask about associated urinary symptoms.
• Is the haematuria worse with exercise?
• Ask about loin pain (present with pyelonephritis or renal calculi).
• Ask about colicky pain. This suggests a ureteric calculus.
• Is there a history of trauma?
• Does the patient have a vaginal or penile discharge?
CLINICAL NOTES
Ask when in the urinary stream the patient notices the blood. Patients may not volunteer this information because they do not think it is important.
• If the urine is bloodstained at the start of micturition and clears later, the site of disease is likely to be the urethra or prostate.
• If the urine is more bloodstained towards the end of micturition, the site of disease is likely to be the bladder.
• If the urine is evenly bloodstained throughout micturition, the site of disease is likely to be the kidney or ureter.
Initial tests
• Gross appearance: visible asymptomatic haematuria in patients older than 45years should always make you consider malignancy (Fig 15.3).
• Urinary dipstick: provides initial information about the presence or absence and degree of protein and haematuria. It also tests for nitrites/leucocytes/ketones/pH and glucose.
• Microscopy and culture (midstream urine): infection.
• Early morning urine: acid-fast bacilli if tuberculosis is suspected.
• Cytology: malignancy.
97